127 related articles for article (PubMed ID: 38372033)
1. Analyzing the value of delayed 18 F-FDG PET/CT images in diagnosing small colorectal cancer liver metastases in patients with hypothyroidism based on diagnostic accuracy and image standardized uptake value.
Pei Y; Wang Z; Hao S; Tong Y; Wu R; Qiao X; Liu Y; Zhang G
Nucl Med Commun; 2024 May; 45(5):396-405. PubMed ID: 38372033
[TBL] [Abstract][Full Text] [Related]
2. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
[TBL] [Abstract][Full Text] [Related]
3. Relationship between KRAS mutations and dual time point
Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on
Zirakchian Zadeh M
Clin Exp Metastasis; 2023 Dec; 40(6):465-491. PubMed ID: 37682423
[TBL] [Abstract][Full Text] [Related]
6. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
10. Detection of Liver Lesions in Colorectal Cancer Patients Using
Boanova LG; Altmayer S; Watte G; Raupp AA; Francisco MZ; De Oliveira GS; Hochhegger B; Andrade RGF
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001662
[TBL] [Abstract][Full Text] [Related]
11. PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
Goshen E; Davidson T; Zwas ST; Aderka D
Technol Cancer Res Treat; 2006 Feb; 5(1):37-43. PubMed ID: 16417400
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic performance of
Samim M; Molenaar IQ; Seesing MFJ; van Rossum PSN; van den Bosch MAAJ; Ruers TJM; Borel Rinkes IHM; van Hillegersberg R; Lam MGEH; Verkooijen HM
Surg Oncol; 2017 Mar; 26(1):37-45. PubMed ID: 28317583
[TBL] [Abstract][Full Text] [Related]
13. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
[TBL] [Abstract][Full Text] [Related]
14. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
[TBL] [Abstract][Full Text] [Related]
16. Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Revheim ME; Haugvik SP; Johnsrud K; Mathisen Ø; Fjeld JG; Skretting A
Acta Radiol; 2015 Apr; 56(4):397-403. PubMed ID: 24682406
[TBL] [Abstract][Full Text] [Related]
17. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
[TBL] [Abstract][Full Text] [Related]
18. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
van Kessel CS; Buckens CF; van den Bosch MA; van Leeuwen MS; van Hillegersberg R; Verkooijen HM
Ann Surg Oncol; 2012 Sep; 19(9):2805-13. PubMed ID: 22396005
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
